Drug
Azd-7325 clinical trials
Also written AZD7325.
- studies test it
- 15
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
- AZD7325
- 12
Studies by the year they started
15 studies that test it; most in 2008 (7)
| Year | Studies |
|---|---|
| 2008 | 7 |
| 2009 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 12
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 4
AstraZeneca (11) · University College, London (2) · Children's Hospital Medical Center, Cincinnati (1) · University of California, Los Angeles (1)
Often tested with
Tested in the same studies.
Lorazepam (1) · Midazolam (1) · Caffeine (1) · Ethinyl Estradiol/Norgestimate (1)
Studies
Open first, then newest update. How each study uses azd-7325 is read from its arms, and is right about nine times in ten.
Testing it · 15
- An Initial Study of AZD7325 in Adults With Fragile X SyndromeCompletedPhase 1Children's Hospital Medical Center, CincinnatiNCT03140813Written as AZD7325 (High-Dose)
- Effects of GABA Modulator AZD7325 on Cutaneous SensationCompletedPhase 1University College, LondonNCT02530580Written as 20 mg AZD7325
- Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism TrialCompletedPhase 2University of California, Los AngelesNCT01966679Written as AZD7325
- Effects of GABA Modulator AZD7325 on Cortical ExcitabilityCompletedPhase 1University College, LondonNCT02135198Written as 2 mg AZD7325
- AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)CompletedPhase 2AstraZenecaNCT00808249Written as AZD7325
- AZD7325 Japan Multiple Ascending Dose (MAD) StudyTerminatedPhase 1AstraZenecaNCT00945425Written as AZD7325
- Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral AdministrationSuspendedPhase 1AstraZenecaNCT00940641Written as AZD7325
- A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.CompletedPhase 1AstraZenecaNCT00720421Written as AZD7325
- Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female SubjectsSuspendedPhase 1AstraZenecaNCT00901290Written as AZD7325
- AZD7325 Multiple Ascending Dose StudyCompletedPhase 1AstraZenecaNCT00681915Written as AZD7325
- Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325CompletedPhase 2AstraZenecaNCT00807937Written as AZD7325
- Study to Evaluate the Abuse Potential of AZD7325 in Healthy Recreational Central Nervous System (CNS) Depressant UsersCompletedPhase 1AstraZenecaNCT00902772Written as AZD7325
- AZD7325 Single Ascending Dose Study in Healthy Male Japanese SubjectsCompletedPhase 1AstraZenecaNCT00769899Written as AZD7325
- Determine the Effect of Multiple Doses of AZD7325, CYP StudyCompletedPhase 1AstraZenecaNCT00790114Written as AZD7325
- Positron Emission Tomography (PET) Study With (11C)Flumazenil to Determine Central GABAA Receptor Occupancy of AZD7325CompletedPhase 1AstraZenecaNCT00681720Written as AZD7325
Codes
What other systems call azd-7325 · ClinicalTrials.gg INT006172
- Wikidata Q27074785One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27074785 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.